Financials data is unavailable for this security.
View more
Year on year HOOKIPA Pharma Inc had net income fall 25.67% from a loss of 64.92m to a larger loss of 81.58m despite a 41.27% increase in revenues from 14.25m to 20.13m.
Gross margin | -- |
---|---|
Net profit margin | -93.16% |
Operating margin | -124.45% |
Return on assets | -30.74% |
---|---|
Return on equity | -48.99% |
Return on investment | -40.15% |
More ▼
Cash flow in USDView more
In 2023, HOOKIPA Pharma Inc did not generate a significant amount of cash. Cash Flow from Financing totalled 65.67m or 326.25% of revenues. In addition the company used 57.52m for operations while cash used for investing totalled 4.16m.
Cash flow per share | -4.23 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 7.14 |
---|---|
Tangible book value per share | 7.14 |
More ▼
Balance sheet in USDView more
Current ratio | 3.86 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼